BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 26722463)

  • 21. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
    Yang F; Lv LZ; Cai QC; Jiang Y
    World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway.
    Liu FY; Zhou SJ; Deng YL; Zhang ZY; Zhang EL; Wu ZB; Huang ZY; Chen XP
    Cell Death Dis; 2015 Mar; 6(3):e1670. PubMed ID: 25741595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway.
    Xu J; Zhu X; Wu L; Yang R; Yang Z; Wang Q; Wu F
    Liver Int; 2012 May; 32(5):752-60. PubMed ID: 22276989
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Growth inhibition of human hepatocellular carcinoma by miRNA-204 via down-regulation of Bcl-2 and Sirt1 expression].
    Li K; Xyu Q; Liu X; Liu Q; Wang M
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Feb; 31(2):168-72. PubMed ID: 25652855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma.
    Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB
    Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Over-expression of miR-141 inhibits the proliferation, invasion and migration of hepatocellular carcinoma MHCC-97H cells].
    Yao B; Xue Y; Liu Z; Xu M; Tu K; Wang J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Aug; 32(8):1083-7. PubMed ID: 27412940
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppressing the CDC37 cochaperone in hepatocellular carcinoma cells inhibits cell cycle progression and cell growth.
    Wang Z; Wei W; Sun CK; Chua MS; So S
    Liver Int; 2015 Apr; 35(4):1403-15. PubMed ID: 25098386
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Inhibitory effects of intervention of the TNFa/NF-kappaB signaling pathway activation on hepatoma cell proliferation].
    Gu X; Yao M; Wang S; Shi Y; Dong Z; Qiu L; Yao D
    Zhonghua Gan Zang Bing Za Zhi; 2014 Jun; 22(6):434-9. PubMed ID: 25203707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [MicroRNA-218 expression and its role in hepatocellular carcinoma].
    Li C; Tu K; Zheng X; Zhang J; Tuo H; Gao J; Yao Y; Liu Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Aug; 33(8):1127-31. PubMed ID: 23996750
    [TBL] [Abstract][Full Text] [Related]  

  • 30. miR-139 regulates the proliferation and invasion of hepatocellular carcinoma through the WNT/TCF-4 pathway.
    Gu W; Li X; Wang J
    Oncol Rep; 2014 Jan; 31(1):397-404. PubMed ID: 24190507
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of microRNA-210 inhibits proliferation of hepatocellular carcinoma cells by targeting YES1.
    Tan W; Lim SG; Tan TM
    World J Gastroenterol; 2015 Dec; 21(46):13030-41. PubMed ID: 26676187
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-451: potential role as tumor suppressor of human hepatoma cell growth and invasion.
    Liu X; Zhang X; Xiang J; Lv Y; Shi J
    Int J Oncol; 2014 Aug; 45(2):739-45. PubMed ID: 24841638
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-184 functions as an oncogenic regulator in hepatocellular carcinoma (HCC).
    Gao B; Gao K; Li L; Huang Z; Lin L
    Biomed Pharmacother; 2014 Mar; 68(2):143-8. PubMed ID: 24183204
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulation of MiR-93 expression reduces cell proliferation and clonogenicity of HepG2 cells.
    Xu D; He XX; Chang Y; Sun SZ; Xu CR; Lin JS
    Hepatogastroenterology; 2012; 59(120):2367-73. PubMed ID: 22773266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Roles of miR-590-5p and miR-590-3p in the development of hepatocellular carcinoma].
    Yang H; Zheng W; Zhao W; Guan C; An J
    Nan Fang Yi Ke Da Xue Xue Bao; 2013 Jun; 33(6):804-11. PubMed ID: 23803188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [miR-491 inhibits the proliferation, invasion and migration of hepatocellular carcinoma cell via down-regulating TPX2 expression].
    Wang J; Liu Z; Dou C; Han S; Li C; Tu K; Yang W
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Apr; 32(4):512-7. PubMed ID: 27053618
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PKCalpha mediated induction of miR-101 in human hepatoma HepG2 cells.
    Chiang CW; Huang Y; Leong KW; Chen LC; Chen HC; Chen SJ; Chou CK
    J Biomed Sci; 2010 May; 17(1):35. PubMed ID: 20444294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS; Wang F; Chen TC; Yeh CN; Yu MC; Jan YY; Chen MF
    Ann Surg; 2014 Feb; 259(2):346-54. PubMed ID: 24135722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y; Chen J; Wang D; Peng H; Tan X; Xiong D; Huang A; Tang H
    Oncotarget; 2015 Nov; 6(35):38093-106. PubMed ID: 26497554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-505 suppresses proliferation and invasion in hepatoma cells by directly targeting high-mobility group box 1.
    Lu L; Qiu C; Li D; Bai G; Liang J; Yang Q
    Life Sci; 2016 Jul; 157():12-18. PubMed ID: 27259809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.